Medical Xpress news

Medical Xpress / Psilocybin shows context-dependent effects on social behavior and inflammation in female mice

Researchers led by Dr. Claire Foldi at Monash University have discovered that psilocybin, the psychoactive compound found in magic mushrooms, produces subtle but distinct effects on social behavior and inflammation that depend ...

Feb 3, 2026 in Psychology & Psychiatry
Medical Xpress / Pathological lying in teens is associated with executive function deficits, study indicates

Teenagers who are pathological liars also tend to struggle with executive function deficits, such as poor memory or impulse control, researchers have found. This means practitioners may be able to consider treatments centered ...

Feb 3, 2026 in Psychology & Psychiatry
Medical Xpress / Novel antibody targets fat cell protein, offering new approach to treating metabolism-related liver cancer

Liver cancer is one of the three deadliest cancers worldwide, and metabolic dysfunction-related cases have become increasingly common in recent years. A research team from The Hong Kong Polytechnic University (PolyU) has ...

Feb 3, 2026 in Oncology & Cancer
Medical Xpress / High blood pressure uncontrolled in 4 out of 5 Americans

Four out of five American adults with high blood pressure don't have their condition under control, putting them at increased risk for heart disease and dementia, a new study says.

Feb 3, 2026 in Health
Medical Xpress / Babies are born to learn—and they learn by moving

In her 35 years as a psychologist, NTNU researcher Audrey van der Meer has studied everything from baby swimming to what infants learn before they are born. At the core of her work is the idea that babies are born to learn—and ...

Feb 3, 2026 in Neuroscience
Medical Xpress / Protein identified as cause of skin damage after radiotherapy

Radiotherapy is one of the main treatment forms for cancer. Among its most common side effects is skin damage, right up to chronic inflammation and fibroses. At present, such long-term damage can only be treated symptomatically ...

Feb 3, 2026 in Immunology
Medical Xpress / Potent DNA-recombination method developed for large cargo delivery in gene therapy

Delivery of therapeutic genes is essential for gene therapy. Adeno-associated viruses (AAVs) are a prime vector for carrying gene cargoes because of their superior gene segmentation flexibility and robust gene reconstitution ...

Feb 3, 2026 in Biomedical technology
Medical Xpress / How a common immunosuppressive drug injures liver blood vessels

In a human organoid-based mechanistic investigation, researchers revealed how an immunosuppressive drug, antithymocyte globulin (ATG), induces injury to blood vessels in the liver. According to the study, ATG first triggers ...

Feb 3, 2026 in Medications
Medical Xpress / Study shows strong evidence for effectiveness of metastasis-directed radiation therapy in prostate cancer

Metastasis-directed therapy (MDT) significantly improved outcomes in patients with oligometastatic prostate cancer, according to a new study from researchers at The University of Texas MD Anderson Cancer Center published ...

Feb 3, 2026 in Oncology & Cancer
Medical Xpress / Clinical data gaps keeping life-saving antibiotics from children

Life-saving antibiotics that could treat severe infections in babies and children aren't accessible due to a lack of data around safety and dosage, new research shows. Two wide sweeping reviews, led by Murdoch Children's ...

Feb 3, 2026 in Pediatrics
Medical Xpress / Medical AI models need more context to prepare for the clinic: Challenges and potential solutions

Medical artificial intelligence is a hugely appealing concept. In theory, models can analyze vast amounts of information, recognize subtle patterns in data, and are never too tired or busy to provide a response. However, ...

Feb 3, 2026 in Health informatics
Medical Xpress / Runx1 transcription factor modulates opioid analgesia and withdrawal in humans and rodents

A University of Calgary-led international research team has identified a genetic factor that may explain why people respond so differently to opioid pain medications, and why some individuals face greater risk of side effects ...

Feb 3, 2026 in Neuroscience